Silage inoculants
Novonesis silage inoculants use scientifically selected lactic acid bacteria strains to control silage fermentation, preserving dry matter, reducing spoilage losses, and improving feed quality for livestock operations.
Overview
Silage production depends on rapid anaerobic fermentation to lower pH and stabilize forage. Left to epiphytic bacteria alone, fermentation is inconsistent and can result in significant dry matter loss, clostridial spoilage, or aerobic instability at feedout. Novonesis inoculants deliver high concentrations of selected Lactobacillus and Pediococcus strains that dominate fermentation, producing lactic acid efficiently. Different formulations target specific silage types and challenges.
Technical specifications
- Active organisms: selected Lactobacillus and Pediococcus strains at guaranteed CFU counts
- Silage types: grass, corn, whole-crop cereals, alfalfa, high-moisture grain
- Application: spray-applied at harvest via standard silage applicator equipment
- Benefits: accelerated pH drop, reduced dry matter loss, improved aerobic stability at feedout, reduced clostridial spoilage
- Formulations: strain combinations optimized for specific crop types and ensiling conditions
- Storage: stable in dry granular or water-soluble powder formats
Technology readiness level
TRL 9 — established commercial product line with decades of field use in livestock operations globally.
About Novonesis
Novonesis is a global biosolutions company formed in 2024 through the combination of Chr. Hansen and Novozymes. The organization specializes in microbiology and industrial fermentation, developing a diverse range of biosolutions used across more than 30 industries, including food and nutrition, agriculture, household care, and energy. By leveraging science and the power of biology, Novonesis creates innovations that help customers reduce their reliance on fossil-based resources, chemicals, energy, and water. The company operates with a purpose to better the world with biology, focusing on sustainable production and consumption patterns.
For customers and partners, Novonesis provides tailored solutions supported by deep scientific expertise and flexible, global production capabilities. The company serves as a strategic partner, enabling clients to achieve higher yields, improve resource efficiency, and differentiate their own products in the marketplace. With over 11,000 employees worldwide, Novonesis utilizes data-driven insights and AI to accelerate its research and development, ensuring it remains at the forefront of the biosolutions sector and continues to drive long-term value for stakeholders across the globe.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.